Relationship Among Pulmonary Function, Bronchial Hyperresponsiveness, and Atopy in Children with Clinically Stable Asthma

被引:0
作者
Eugene Yang
Woojung Kim
Byoung Chul Kwon
Sung Yeon Choi
Myung Hyun Sohn
Kyu-Earn Kim
机构
[1] Yonsei University College of Medicine,Department of Pediatrics and Institute of Allergy, Brain Korea 21 Project for Medical Sciences
来源
Lung | 2006年 / 184卷
关键词
Asthma; Pulmonary function; Bronchial hyperresponsiveness; Atopy;
D O I
暂无
中图分类号
学科分类号
摘要
Pulmonary function testing plays a key role in the diagnosis and management of asthma in children. However, the literature does not clearly show whether children with clinically stable asthma have significantly reduced lung function when compared with normal children. We compared the lung function of 242 clinically stable asthmatic children who were initially diagnosed with mild intermittent or mild persistent asthma with the lung function of 100 nonasthmatic controls. The lung function was assessed using FEV1, FEV1/FVC, FEF25–75 and PEF. In addition, we measured bronchial hyperresponsiveness (BHR) using the provocation concentration of methacholine needed to produce a 20% fall in FEV1. All measures of pulmonary function were significantly decreased in the children with asthma. Pulmonary function was not influenced by atopy, serum IgE, or total eosinophil count (TEC). However, the likelihood ratio for trends revealed a significant association between our pulmonary parameters and the degree of BHR. Children with mild-to-severe BHR had greatly decreased lung function compared with those with normal BHR, the control group. In addition, a direct correlation was found between PC20 and our pulmonary parameters in asthmatic children. However, only atopic children with asthma had a significant correlation between PC20 and TEC. We found children with clinically stable asthma to have pulmonary obstruction, which associated strongly with their degree of BHR.
引用
收藏
页码:73 / 79
页数:6
相关论文
共 115 条
[1]  
Barnes PJ(1993)Guidelines for the evaluation of impairment/disability in patients with asthma. A statement of the American Thoracic Society Am Rev Respir Dis 147 1202-1218
[2]  
Beehn KM(1998)Current issues for establishing inhaled corticosteroids as the anti-inflammatory agents of choice in asthma J Allergy Clin Immunol 101 427-433
[3]  
Ksoll M(2000)Elevation of total serum immunologlobulin E is associated with asthma in nonallergic individuals Eur Respir J 16 609-614
[4]  
Buhl R(1980)Bronchial hyperreactivity Am Rev Respir Dis 121 389-413
[5]  
Boushey MI(1987)Prospective investigations in asthma. What have we learned from longitudinal studies about lung growth and senescence in asthma? Chest 91 119-126
[6]  
Holtzman MJ(2001)Differential cell counts in sputum in respiratory epidemiology Chest 120 1107-1113
[7]  
Sheller JR(1994)Episodes of respiratory morbidity in children with cough and wheeze Am J Respir Crit Care Med 150 48-53
[8]  
Nadel JA(2000)Guidelines for methacholine and exercise challenge testing—1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am J Respir Crit Care Med 161 309-329
[9]  
Buist SA(1998)Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma Am J Respir Crit Care Med 157 4-9
[10]  
Vollmer WM(1980)The prevalence and incidence of asthma and asthma-like symptoms in a general population sample Am Rev Respir Dis 122 567-575